Arvisol placebo, Arvisol 150mg
APHP180619
Phase 2 small_molecule active
Quick answer
Arvisol placebo, Arvisol 150mg for Patients with severe Alcohol Use Disorder (according to DSM 5) at entry of a scheduled inpatient alcohol cessation attempt is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Patients with severe Alcohol Use Disorder (according to DSM 5) at entry of a scheduled inpatient alcohol cessation attempt
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active